Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.25 USD | +0.93% | +2.20% | -15.36% |
04-04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
04-04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.
- Official Publications